Full Text View
Tabular View
No Study Results Posted
Related Studies
SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
This study has been terminated.
( The pharmaceutical company discontinued further development of SU5416. )
Study NCT00006247   Information provided by Pediatric Brain Tumor Consortium
First Received: September 11, 2000   Last Updated: October 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Neoplasms
Neoplasms by Site
Nervous System Diseases
Interventions listed in this trial
semaxanib
Additional drug interventions recognized in this trial
SU 5416
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services